Use of botulinum toxins for chronic headaches: A focused review

Clinical Journal of Pain

Volumn 18, Issue 6 SUPPL., 2002, Pages

  Loder, Elizabeth ^a   Biondi, David ^a  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

Botox; Botulinum toxin; Headache; Myobloc; Pain

Indexed keywords

ANTIMIGRAINE AGENT; BOTULINUM TOXIN A; BOTULINUM TOXIN B; METHYLPREDNISOLONE;

ANALGESIA; CHRONIC DISEASE; CLINICAL TRIAL; CLUSTER HEADACHE; DIPLOPIA; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG USE; HEADACHE; HUMAN; INFLAMMATION; MIGRAINE; MUSCLE CONTRACTION; MUSCLE TONE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PTOSIS; REVIEW; RISK FACTOR; TENSION HEADACHE; WHIPLASH INJURY;

BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; CLUSTER HEADACHE; HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; TENSION-TYPE HEADACHE; TREATMENT OUTCOME; VASCULAR HEADACHES; WHIPLASH INJURIES;

EID: 0036840845     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200211001-00009     Document Type: Review

References (38)

1. Rasmussen BK, Jensen R, Schroll M, et al. Epidemiology of headache in a general population: A prevalence study. J Clin Epidemiol 1991;44:1147-57.
2. Scher AI, Stewart WF, Liberman J. et al. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.
3. Schwartz BS, Stewart WF, Simon D, et al. Epidemiology of tension-type headache. JAMA 1998;279:381-3.
4. Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 1981;33:155-88.
5. Volknandt W. Commentary: The synaptic vesicle and its targets. Neuroscience 1995;64:277-300.
6. Ergbuth FJ, Naumann M. Historical aspects of botulinum toxin. Neurology 1999;53:1850-3.
7. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87:1044-9.
8. Carruthers JDA, Carruthers A. Botulinum A exotoxin in clinical ophthalmology. Can J Ophthalmol 1996;31:389-400.
9. Botox® Package Insert. Allergan Pharmaceuticals, San Diego, CA.
10. Myobloc™ package insert. 2000 Elan Pharmaceuticals, South San Francisco, CA.
11. Binder WJ, Brin MF, Blitzer A, et al. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study. Otolaryngol Head Neck Surg 2000;123:669-76.
12. Silberstein S, Mathew N, Saper J, et al. Botulinum toxin type A as a migraine preventive treatment. Headache 2000;40:445-50.
13. Brin MF, Swope DM, O'Brien C, et al. Botox for migraine: Double-blind, placebo-controlled, region-specific evaluation. Cephalalgia 2000;20:421 (abstract).
14. Opida C, Open-label study of Myobloc (botulinum toxin type B) in the treatment of patients with transformed migraine headaches. J Pain 2002;3(suppl 1):10 (abstract).
15. Klapper JA, Klapper A. Use of botulinum toxin in chronic daily headaches associated with migraine. Headache Q 1999;10:141-3.
16. Klapper JA, Mathew NT, Klapper A, et al. Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache. Cephalalgia 2000;20:292-3 (abstract).
17. Argoff C. Successful treatment of chronic daily headache with Myobloc. J Pain 2002;3(suppl 1):10 (abstract).
18. Freund BJ, Schwartz M. A focal dystonia model for subsets of chronic tension headache. Cephalalgia 2000;20:433 (abstract).
19. Zwart JA, Bovim G, Sand T, et al. Tension headache: Botulinum toxin paralysis of temporal muscles. Headache 1994;34:458-62.
20. Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997;4(suppl 2):S71-3.
21. Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998;38:468-71.
22. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: A pilot study. Eur J Med Res 1999;4:183-6.
23. Smuts JA, Baker MK, Smuts HM, et al. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Ear J Neurol 1999;6(suppl 4):S99-102.
24. Porta M. A comparative trial of botulinum toxin A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain 2000;4:31-5.
25. Göbel H, Lindner V, Krack PK, et al. Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia 1999;19:455 (abstract).
26. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: A pilot study. Headache 2000; 40:231-6.
27. Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache 1997;37:253-5.
28. Smuts JA, Barnard PWA. Botulinum toxin type A in the treatment of headache syndromes: A clinical report of 79 patients. Cephalalgia 2000;20:332 (abstract).
29. Robbins L. Botulinum toxin for cluster headache. Poster presentation at the 10th Congress of the International Headache Society, New York, NY. June 29-July 2, 2001.
30. Opida C. Evaluation of Myobloc (botulinum toxin type B) in patients with post-whiplash headaches. Presented at the American Academy of Neurology Annual Meeting, Denver, CO. April 13-18, 2002.
31. Freund BJ, Schwartz M. The use of botulinum toxin-A in the treatment of refractory cluster headache: Case reports. Cephalalgia 2000;20:329-30.
32. Ginies PR, Fraimout JL, Kong A, et al. Treatment of cluster headache by subcutaneous injection of botulinum toxin. Presented at the 8th World Congress on Pain, Vancouver, Canada; August 1996.
33. Rolinik JD, Karst M, Fink M, et al, Botulinum toxin type A and EMG: A key to the understanding of chronic tension-type headache? Headache 2001;41:985-9.
34. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990;40:277-80.
35. Aoki KR, Cui M. Botulinum toxin type A: Potential mechanisms of action in pain relief. Presented at the 37th Annual Meeting of the Interagency Botulinum Research Coordinating Committee, Asilomar, CA. Oct 17-20, 2000.
36. Welch MJ. Sensitivity of embryonic rat dorsal ganglia neurons to Clostridium botulinum neurotoxins. Int Soc Toxinol 2000;38:245-58.
37. Loder EW. Migraine management: An overview of nonpharmacologic and pharmacologic interventions. Special report: Advanced strategies for managing migraine. Postgrad Med 1998;13-19.
38. Hallet, M. One man's poison - Clinical applications of botulinum toxin. N Engl J Med 1999;342:118-20.